Imec’s miDiagnostics joint venture does blood tests from blood-drop

Within minutes, the data resulting from these complex tests will be sent to smartphones or other mobile devices where they will be processed and displayed. This is intended to bring complex diagnostic tests to the local point of need at an affordable cost, with a high level of comfort and confidence for both patients and caregivers.

“The expertise that is available in miDiagnostics is truly unique” said its CEO Dr Hilja Ibert (pictured). “Imec’s and Johns Hopkins’ teams have been pioneers in bringing biological tests to chips in a silicon technology that can be produced in high volumes,” she said.

“The tools developed by miDiagnostics have the potential to bring affordable clinical diagnostics to people and places where no such tests were available,” said Bob Bollinger, professor of infectious diseases at Johns Hopkins, “and with medicine evolving towards personalised treatments, they could enable appropriate testing without burdening healthcare budgets.”

Luc Van den hove, CEO of Imec, said “From our long-standing expertise with silicon nanoelectronics, we know that this technology offers enormous opportunities in terms of boosting medical diagnostics.”